• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ALAIR; BRONCHIAL THERMOPLASTY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ALAIR; BRONCHIAL THERMOPLASTY SYSTEM Back to Search Results
Model Number M005ATS25020
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Asthma (1726); Respiratory Tract Infection (2420); No Code Available (3191)
Event Date 02/28/2016
Event Type  Injury  
Manufacturer Narrative
(b)(6).Study source: e7086 bsc bt registry.The complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that an alair bronchial thermoplasty (bt) catheter was used during a bt procedure performed on (b)(6) 2016 as part of the bsc (b)(6) study.On (b)(6) 2016 the patient was admitted for the bt procedure as planned by the physician.On (b)(6) 2016 the patient underwent the first bt treatment to the right lower lobe of the lungs.No issues were noted with the device.According to the complainant, on (b)(6) 2016, while hospitalized for observation following the bt procedure, the patient experienced post-procedure bronchospasm, cough, and whitish expectoration.The patient was treated with prednisone and was discharged from the hospital on (b)(6) 2016 as planned by the physician for prophylactic reasons.On (b)(6) 2016 the patient experienced upper respiratory tract infection (urti) and was treated with medication (exact type not reported).No hospitalizations or er visits occurred due to this event.On (b)(6) 2016 the urti had resolved.Baseline spirometry values visit date: (b)(6) 2016: pre-bronchodilator, fev1: 2.64, fev1 % predicted: 66.10, fvc: 4.01, fvc % predicted: 83.50.Post-bronchodilator: fev1: 3.71, fev1 % predicted: 93.10, fvc: 5.04, fvc % predicted: 105.00.
 
Manufacturer Narrative
Study source: (b)(6).(b)(4).The complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.Updated based on additional information received on september 16, 2019.
 
Event Description
It was reported to boston scientific corporation that an alair bronchial thermoplasty (bt) catheter was used during a bt procedure performed on (b)(6) 2016 as part of the (b)(6) study.On (b)(6) 2016 the patient was admitted for the bt procedure as planned by the physician.On (b)(6) 2016 the patient underwent the first bt treatment to the right lower lobe of the lungs.No issues were noted with the device.According to the complainant, on (b)(6) 2016, while hospitalized for observation following the bt procedure, the patient experienced post-procedure bronchospasm, cough, and whitish expectoration.The patient was treated with prednisone and was discharged from the hospital on (b)(6) 2016 as planned by the physician for prophylactic reasons.On (b)(6) 2016 the patient experienced upper respiratory tract infection (urti) and was treated with medication (exact type not reported).No hospitalizations or emergency room visits occurred due to this event.On (b)(6) 2016 the urti had resolved.Baseline spirometry values: visit date: (b)(6) 2016, (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALAIR
Type of Device
BRONCHIAL THERMOPLASTY SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
model farm road
marlborough MA 01752
MDR Report Key6848247
MDR Text Key85123324
Report Number3005099803-2017-02742
Device Sequence Number1
Product Code OOY
Combination Product (y/n)N
PMA/PMN Number
P080032
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2017
Device Model NumberM005ATS25020
Device Catalogue NumberATS 2-5
Device Lot Number0017994933
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/11/2017
Initial Date FDA Received09/07/2017
Supplement Dates Manufacturer Received09/16/2019
Supplement Dates FDA Received10/03/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/21/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age36 YR
Patient Weight114
-
-